Alpad, Tolindon M.
HRN: 00-06-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/05/2022
11/12/2022
IV
2.25g
Q6
Aspiration Pneumonia
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes